Welcome to our dedicated page for Inogen news (Ticker: INGN), a resource for investors and traders seeking the latest updates and insights on Inogen stock.
Inogen Inc (INGN) is a pioneering medical technology company specializing in portable oxygen concentrators for respiratory care. This dedicated news hub provides investors and healthcare professionals with essential updates on product developments, regulatory milestones, and strategic initiatives.
Access timely announcements including quarterly earnings reports, FDA clearances for new devices, partnership agreements with healthcare providers, and clinical study results. Our curated collection ensures you stay informed about innovations in oxygen therapy technology and market expansion efforts.
Key focus areas include advancements in lightweight oxygen systems, international distribution updates, and operational developments impacting respiratory patient care. Bookmark this page for direct access to primary source materials and analyzed updates from INGN's corporate communications.
Inogen, Inc. (Nasdaq: INGN) announced their first quarter 2024 financial results, showing an 8.1% increase in total revenue to $78.0 million, accompanied by a total gross margin of 44.1%. The GAAP net loss was $14.6 million, with adjusted net loss at $10.4 million. Adjusted EBITDA was a negative $7.6 million. Inogen expects revenue for the second quarter of 2024 to be in the range of $81 million to $84 million. The company remains focused on revenue growth, profitability, and innovation to enhance their market position.
FAQ
What is the current stock price of Inogen (INGN)?
What is the market cap of Inogen (INGN)?
